journal article·2019-12-04Open access

The effect of chrysin–curcumin-loaded nanofibres on the wound-healing process in male rats

Zoheyr Mohammadi, Mohsen Sharif Zak, Hasan Majdi, Ebrahim Mostafavi, Meisam Barati, Hamid Lotfimehr, Kambiz Ghaseminasab, Hamidreza Pazoki-Toroudi, Thomas J. Webster, Abolfazl Akbarzadeh

Abstract

AIM: The aim of the present study was to produce chrysin-curcumin-loaded PCL-PEG nanofibres by an electrospinning technique and to evaluate the biological activity of the chrysin-curcumin-loaded PCL-PEG fibres for wound healing and its related genes using in vivo methods. MATERIALS AND METHODS: The electrospinning method was carried out for the preparation of the chrysin, curcumin and chrysin-curcumin-loaded PCL-PEG nanofibres with different concentrations. FTIR and SEM were performed to characterize the chemical structures and morphology of the nanofibres. In vitro drug release, as well as in vivo wound-healing studies were investigated in male rats. The expressions of genes related to the wound-healing process were also evaluated by real-time PCR. RESULTS: Our study showed that the chrysin-curcumin-loaded nanofibres have anti-inflammatory properties in several stages of the wound-healing process by affecting the IL-6, MMP-2, TIMP-1, TIMP-2 and iNOS gene expression. Our results demonstrated that the effect of the chrysin-loaded nanofibre, the curcumin-loaded nanofibre and the chrysin-curcumin-loaded nanofibre in the wound-healing process is dose dependent and in accordance with the obtained results in that it might affect the inflammation phase more than the other stages of the wound-healing process. CONCLUSION: We have introduced chrysin-curcumin-loaded PCL-PEG nanofibres as a novel compound for shortening the duration of the wound-healing process.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Curcumin's Biomedical Applications · Electrospun Nanofibers in Biomedical Applications · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences

Department of Clinical Biochemistry, Faculty of Medical Sciences, Tabriz University of Medical Sciences

Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences

Department of Chemical Engineering, Northeastern University

School of Nutrition and Food Technology, Cellular and Molecular Nutrition Department, Shahid Beheshti University of Medical Sciences

Department of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences

Department of Biochemistry, School of Medicine, Iran University of Medical Sciences

Physiology Research Center and Department of Physiology, Iran University of Medical Sciences

Tuberculosis and Lung Disease Research Center of Tabriz, Tabriz University of Medical Sciences

Universal Scientific and Education Network (USERN)

Funding

Tabriz University of Medical Sciences

References (63)

Show source-provided references
1. 10.1111/cbdd.1299610.1111/cbdd.12996 ↗
2. Tan L, Hou Z, Gao Y. Efficacy of combined treatment with vacuum sealing drainage and recombinant human epidermal growth factor for refractory wounds in the extremities and its effect on serum levels of IL-6, TNF-α and IL-2. Exp Ther Med. 2018;15:288–294.
3. 10.1023/A:101441772832510.1023/A:1014417728325 ↗
4. 10.1002/lsm.190009011110.1002/lsm.1900090111 ↗
5. 10.1177/153473460527573310.1177/1534734605275733 ↗
6. 10.1096/fj.00-0490fje10.1096/fj.00-0490fje ↗
7. 10.1016/S0190-9622(86)70238-710.1016/S0190-9622(86)70238-7 ↗
8. 10.1007/s00595-004-2827-010.1007/s00595-004-2827-0 ↗
9. 10.1016/S0039-6109(02)00202-510.1016/S0039-6109(02)00202-5 ↗
10. 10.2174/138920101766616072112310910.2174/1389201017666160721123109 ↗
11. 10.1111/j.1468-3083.2004.01138.x10.1111/j.1468-3083.2004.01138.x ↗
12. 10.3109/15569527.2011.58125710.3109/15569527.2011.581257 ↗
13. 10.1080/00365529975002504810.1080/003655299750025048 ↗
14. 10.2165/11538930-000000000-0000010.2165/11538930-000000000-00000 ↗
15. 10.1097/01.prs.0000225430.42531.c210.1097/01.prs.0000225430.42531.c2 ↗
16. 10.1126/science.276.5309.7510.1126/science.276.5309.75 ↗
17. 10.3390/ijms1808181910.3390/ijms18081819 ↗
18. 10.1097/00001432-200404000-0000410.1097/00001432-200404000-00004 ↗
19. Browne AC, Vearncombe M, Sibbald RG. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft. Ostomy Wound Manage. 2001;47:44–49.
20. Shivakumar M, Ramalingam S, Natarajan D. Larvicidal potential of some India medicinal plant extracts against Aedes aegypti (L). Asian J Pharm Clin Res. 2013;6: 77-80.
21. 10.1007/978-81-322-2704-510.1007/978-81-322-2704-5 ↗
22. Mukhtar MD, Sani A, Yakasai AA. Cytotoxicity of fractions of Pistia stratiotes l. On larvae of Culex mosquito and A. salina. Anim Res Int. 2004;1; 95-99.
23. Karou SD, Savadogo A, Canini A, et al. Antibacterial activity of alkaloids from Sida acuta. Afr J Biotechnol. 2006;5; 195-200.
24. Chelela B, Chacha M, Matemu A. Larvicidal potential of wild mushroom extracts against Culex quinquefasciatus Say, Aedes aegypti and Anopheles gambiae Giles S.S. Am J Res Commun. 2014;2:2325–4076.
25. 10.1016/S1995-7645(11)60009-610.1016/S1995-7645(11)60009-6 ↗
26. 10.1111/j.1365-2672.1992.tb04993.x10.1111/j.1365-2672.1992.tb04993.x ↗
27. 10.1100/tsw.2011.7810.1100/tsw.2011.78 ↗
28. Mostafavi, E. Soltantabar, P. Webster, TJ. Nanotechnology and picotechnology: A new arena for translational medicine. In: Biomaterials in translational medicine. Academic Press; 2019. p. 191–212.
29. 10.1016/S1043-6618(03)00248-210.1016/S1043-6618(03)00248-2 ↗
30. 10.1016/j.ultsonch.2017.06.00710.1016/j.ultsonch.2017.06.007 ↗
31. 10.1080/21691401.2018.143983910.1080/21691401.2018.1439839 ↗
32. 10.3390/pharmaceutics304079310.3390/pharmaceutics3040793 ↗
33. Mat Nor MS, Manan Z, Mustaffa A, et al. Solubility prediction of flavonoids using new developed UNIFAC-based model. Chem Eng Trans. 2017;56: 799-804.
34. 10.1021/acsomega.8b0121910.1021/acsomega.8b01219 ↗
35. 10.1038/eye.2017.23810.1038/eye.2017.238 ↗
36. 10.1189/jlb.080239710.1189/jlb.0802397 ↗
37. 10.1089/ars.2017.726310.1089/ars.2017.7263 ↗
38. 10.1016/S0046-8177(99)90140-510.1016/S0046-8177(99)90140-5 ↗
39. A Abd El-Aleem S, Muftah AA, B Jude E. Immunohistochemical characterization of the inflammatory responses in wound healing and the use of the subcutaneous polyvinyl alcohol (PVA) sponge implantation for evaluation of the healing process. J Cytol Histol. 2018;09: 519.10.4172/2157-7099.1000519 ↗
40. 10.1067/msy.2001.11583710.1067/msy.2001.115837 ↗
41. Ellies LG, Hingorani DV, Lippert CN, et al. Impact of MMP-2 and MMP-9 activation on wound healing. Tumor Growth and RACPP Cleavage. BioRxiv . 2018: 327791.
42. 10.1111/1523-1747.ep1235959010.1111/1523-1747.ep12359590 ↗
43. 10.1111/j.1600-065X.1992.tb01407.x10.1111/j.1600-065X.1992.tb01407.x ↗
44. 10.1089/wound.2013.048510.1089/wound.2013.0485 ↗
45. 10.1002/jcp.2532810.1002/jcp.25328 ↗
46. 10.1002/mnfr.20160011210.1002/mnfr.201600112 ↗
47. 10.1007/s12031-015-0636-010.1007/s12031-015-0636-0 ↗
48. 10.1016/j.freeradbiomed.2010.06.02410.1016/j.freeradbiomed.2010.06.024 ↗
49. Arabian M, Aboutaleb N, Soleimani M, et al. Role of morphine preconditioning and nitric oxide following brain ischemia reperfusion injury in mice. Iran J Basic Med Sci. 2015;18:14–21.
50. 10.1155/2017/695679410.1155/2017/6956794 ↗
51. 10.1039/9781788012942-0013610.1039/9781788012942-00136 ↗
52. 10.1517/17425247.2016.114252510.1517/17425247.2016.1142525 ↗
53. 10.1039/C7PY00038C10.1039/C7PY00038C ↗
54. 10.1016/j.jddst.2017.07.00310.1016/j.jddst.2017.07.003 ↗
55. 10.1126/science.141156910.1126/science.1411569 ↗
56. 10.1002/jlb.66.4.60110.1002/jlb.66.4.601 ↗
57. 10.1016/S1074-7613(00)80334-910.1016/S1074-7613(00)80334-9 ↗
58. Salo T, Mäkelä M, Kylmäniemi M, et al. Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest. 1994;70:176–182.
59. 10.1089/wound.2014.058110.1089/wound.2014.0581 ↗
60. Ravanti L, Toriseva M, Penttinen R, et al. Expression of human collagenase-3 (MMP-13) by fetal skin fibroblasts is induced by transforming growth factor beta via p38 mitogen-activated protein kinase. FASEB J. 2001;15: 1098-1100.
61. 10.1046/j.1524-475X.1998.60206.x10.1046/j.1524-475X.1998.60206.x ↗
62. 10.1038/sj.jid.570008410.1038/sj.jid.5700084 ↗
63. 10.1016/S0002-9610(03)00296-410.1016/S0002-9610(03)00296-4 ↗